KUALA LUMPUR, Nov 7 (Bernama) -- The Polyplastics Group, a leading global supplier of engineering thermoplastics, has introduced an approach of using its less heat-resistant plastics products for electric vehicle (EV) cooling components.
According to a statement, Polyplastics sees strong potential for less heat-resistant plastics such as polyoxymethylene (POM) and polypropylene (PP) for production and manufacturing of EV cooling components.
As the automotive industry moves from traditional combustion engine vehicles to battery electric vehicles (BEVs), original equipment manufacturers (OEMs) and parts manufacturers are reimagining the types of materials that can meet the thermal management needs of EVs.
The coolant in combustion engines is typically maintained at a temperature of 70 to 100 degrees celsius (ºC) but can climb to 120 ºC or higher if the engine overheats. Therefore, metals or highly heat-resistant plastics like polyphenylene sulphide (PPS) are used in cooling components and lines.
In comparison, EVs require a long-life coolant (LLC) temperature of 100 ºC or lower, allowing for the use of less heat-resistant materials for BEV-specific components.
When the temperature of an LLC is 100 ºC or lower, general-purpose engineering plastics like POM or PP can be used instead of metals or high-performance engineering plastics.
In the case of PP, Polyplastics sees potential for PP-LGF (long glass fibre) instead of short glass fibre to increase strength, dimensional accuracy, and overall performance.
Replacing highly heat-resistant plastics such as PPS with POM and PP not only reduces material costs but also helps with efforts to reduce carbon dioxide by reducing the carbon footprint of materials and energy consumption during moulding.
-- BERNAMA
Tuesday, 7 November 2023
POLYPLASTICS INTRODUCES LESS HEAT-RESISTANT PLASTICS FOR EV
MARKET SIMPLIFIED’S LOW-CODE APPLICATION PLATFORM BESPOKE TO APAC FINANCIAL SERVICES
KUALA LUMPUR, Nov 7 (Bernama) -- Market Simplified, a leader in advanced enterprise financial solutions has introduced Nitro XP, an innovative Low-Code Application Platform (LCAP), revolutionising financial services in the dynamic Asia Pacific (APAC) market.
According to Market Simplified in a statement, the official launch for APAC will be held during the Singapore Fintech Festival 2023 on Nov 15.
With 18 years of unparalleled expertise in financial applications, Nitro XP signifies the company’s dedication to addressing the intricate needs of the financial sector.
Launched successfully in India six months ago, Nitro XP has gained significant momentum, attracting prominent large enterprises as well as small and medium enterprises (SMEs) looking to develop lending and trading solutions on the platform.
The platform expedites application development for financial institutions, enhancing efficiency and reducing time-to-market. It is a valuable asset for businesses of all sizes, strengthening digital infrastructure, fostering innovation, and enhancing competitiveness.
Nitro XP also prioritises user experience, performance, security, and scalability, thus enabling the development of robust, adaptable applications that drive business growth.
Offering unparalleled benefits to financial institutions, the platform’s drag-and-drop visual interface empowers users to create tailored applications without complex coding, reducing development timelines and costs.
In addition, Nitro XP's library of pre-built components expedites commonly used financial applications, allowing enterprises to optimise resource allocation, and it adapts to the requirements of large financial institutions to ensure smooth operations.
A trailblazing provider of cutting-edge enterprise financial solutions, Market Simplified continues to provide the tools and solutions needed for success in the evolving financial landscape.
-- BERNAMA
Saturday, 4 November 2023
AM Best Affirms KB Insurance Credit Ratings As Excellent
KUALA LUMPUR, Nov 3 (Bernama) -- Global credit rating agency, AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) of South Korea’s KB Insurance Co Ltd (KBI).
In a statement, AM Best said the credit ratings (ratings) which have a stable outlook, reflected KBI’s balance sheet strength, was assessed as strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management.
The ratings also reflect the support that the company receives from its parent, KB Financial Group Inc (KB Group) and its strategic importance to KB Group.
KBI’s risk-adjusted capitalisation has remained at a very strong level, as measured by Best’s Capital Adequacy Ratio, in which the company exhibited good accessibility to the capital market through the recent issuances of subordinated bonds.
Other balance sheet strength considerations include KBI’s relatively low debt leverage and healthy coverage ratios, as well as its conservative investment strategy.
AM Best assesses the company’s operating performance as adequate, with a weighted five-year average consolidated return-on-equity ratio of 9.0 per cent (2018-2022) and an operating ratio of 96.4 per cent.
Its underwriting profitability improved materially in 2022, mainly driven by favourable long-term line performance as a result of decreased medical indemnity loss ratio due to several rounds of rate hikes and stabilised medical claims.
In addition, KBI’s investment income continues to be a major source of earnings with a stable trend in its net investment returns.
As a wholly owned subsidiary of KB Group, one of the largest financial holding companies in South Korea, KBI remained the fourth-largest non-life insurer in South Korea with a stable market share of approximately 13 per cent, based on gross premiums written in 2022.
-- BERNAMA
Friday, 3 November 2023
NEW TRANSPORTATION MEANS AT TOMORROW.MOBILITY WORLD CONGRESS
KUALA LUMPUR, Nov 3 (Bernama) -- Fira de Barcelona and EIT Urban Mobility, an initiative of the European Institute of Innovation and Technology (EIT) and a body of the European Union will jointly organised Tomorrow.Mobility World Congress (TMWC) from Nov 7 to 9 in Barcelona, Spain.
Deemed an ultimate platform for sustainable and intelligent urban mobility, over 100 international experts will come together at the event, to address the crucial challenges the transportation sector is facing and share effective, proven solutions.
The conference programme is structured around eight themes, namely Data Spaces; Inclusivity, Affordability & Fairness; Connected, Cooperative & Automated Mobility; Sustainable Urban Logistics; Multimodality; Urban Air Mobility; Energy Transition; and Active Mobility, according to a statement.
TMWC will focus on some of the key topics, including strategies to support public transport as a crucial element to make cities more liveable and meet ambitious emission reduction targets, the creation of a shared mobility data space to deploy extensive multimodal travel, and overcoming the challenges to fully implement autonomous vehicles.
Among some 100 speakers are San Francisco MTA Chief Innovation Officer and X (Alphabet’s Moonshot Factory) advisor, Timothy Papandreou; Chair of the Committee on Transport and Tourism at the European Parliament, Karima Delli; and Los Angeles Metropolitan Transportation Authority Chief Innovation Officer, Seleta Reynolds.
The congress will also feature an exhibition space where 130 companies including BSM, Deloitte, KIA, Moventis, PTV Group, PricewaterhouseCoopers, Racc, Renfe, and Sener will showcase their latest products.
TMWC will be held alongside Smart City Expo World Congress, Tomorrow.Building, Tomorrow.BlueEconomy, focusing on the opportunities of the blue economy, apart from PUZZLE X, in which all together the events will gather over 25,000 visitors, 1,000 exhibitors, over 800 cities and more than 600 speakers in Barcelona.
-- BERNAMA
BOLT.EARTH AND TAIZHOU CHINV SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD STRENGTHEN LONG-STANDING PARTNERSHIP TO REVOLUTIONIZE ELECTRIC VEHICLE ECOSYSTEM
Driving Innovation: Bolt.Earth and Chinv Redefine the Future of Electric Mobility at EICMA 2023 (Graphic: Business Wire)
Drive Smart. Ride Connected. The Future of E-Mobility is Unfolding
SINGAPORE, Nov 3 (Bernama-BUSINESS WIRE) -- Bolt.Earth, a Singapore-based pioneer in the connected EV Operating System market, further strengthens its partnership with Chinv, the renowned designer and manufacturer of EV 2-wheeler bikes. Together, they are set to redefine the future of electric mobility at this year’s EICMA 2023 at Fiera Milano-Rho Milan. Witness the synergy of Chinv’s design mastery and Bolt.Earth’s smart operating stack, merging years of collaborative effort to produce an EV experience like no other.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231101137680/en/
Jyotiranjan Harichandan, Co-Founder at Bolt.Earth, remarked, “Our journey with Chinv has been truly transformative. This partnership, built on a mutual vision and relentless innovation, is about redefining sustainable transport. Chinv’s exceptional experience in hardware design & development, combined with our charging and vehicle operating stack, is laying the groundwork for the future.”
The convergence of Bolt.Earth’s advanced software solutions and Chinv’s hardware design and development expertise signals a transformative phase for sustainable transportation. This venture aims to elevate electric vehicles, ensuring they are environmentally responsible and technologically superior.
Ms. Xu Duo (Rita), President of Chinv expressed, “Our alliance with Bolt.Earth represents a bold step towards a smarter, more sustainable horizon. The potential to revolutionize the EV sphere is immense, and together, we are poised to lead this change.”
Join us at EICMA 2023, held from November 7th to November 12th at Fiera Milano-Rho Milan, where Bolt.Earth will be showcasing their latest offerings at booth number C-49 in Hall Number 14, in association with Chinv along with an amazing virtual reality experience.
About Chinv
Chinv, founded in Hong Kong in 2006, operates under multiple brands, including "OKLA" for electric vehicles, "Motrac" for gasoline vehicles, "O-Town" for clothing, "OKLATEC" for R&D and "CHINV" for lights and electric parts; redefining the way we move and setting new standards for eco-friendly mobility, with a vision to drive positive change and a goal to develop cleaner and more efficient transportation solutions.
OKLATEC has R&D experience in designing over 50 motorcycles, ranging (from ICE to EV), for customers worldwide. Building on these milestones, Chinv has been successful in supporting the launch of multiple brands at various integration levels for both electrical and mechanical aspects, covering a wide range from low-speed to high-performance EV motorcycles. As a result, Chinv has become a one-stop solution in the EV motorcycle supply chain.
About Bolt.Earth
Bolt.Earth is on a mission to push emerging markets toward cleaner mobility. The company deploys state-of-the-art embedded smart speedometer clusters that redefine your EV riding experiences. Designed for safety and convenience, Bolt.Earth's speedometer clusters and display units use Bolt.Earth’s OS to provide vehicle management tools, crucial data, anti-theft precautions, and customization options for a smart, connected & modern riding experience. Additionally, Bolt.Earth enables India's largest peer-to-peer EV charging network, with 30,000+ charging points across 1,100 cities. They offer charging solutions for individuals, businesses, real estate companies, fleet operators, and the government. For more information about their solutions, visit bolt.earth.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20231101137680/en/
Contact
Media Contact: marketing@bolt.earth
Source : Bolt.Earth
Thursday, 2 November 2023
RESOLIAN ACQUIRES CHINA-BASED BIOANALYTICAL CRO DENALI MEDPHARMA
MALVERN, Pa. & CHONGQING, China, Nov 2 (Bernama-BUSINESS WIRE) -- Resolian, a global bioanalytical contract research organization (CRO) specializing in drug metabolism and pharmacokinetics for small and large molecules, has acquired Denali Medpharma, a leading China-based bioanalytical CRO. Resolian now has bioanalysis laboratory operations in the U.S., U.K., Australia, and China. The company can initiate a project on four continents and easily transfer validated methods across labs, allowing therapeutic trials to extend to virtually any destination without changing bioanalytical CROs. “The strategic addition of Denali will significantly enhance our capabilities and strengthen our position in the global market,” said Resolian CEO Patrick Bennett. “Denali’s founders and core scientists are internationally recognized across pharmaceutical research and development analysis and we are particularly excited to add Denali’s oligo, mRNA, and liposomal expertise to Resolian’s portfolio of services. We look forward to leveraging our growing company’s strengths to continue driving innovation and creating lasting value for our clients and stakeholders.” “The Denali team is thrilled to join Resolian,” said Denali CEO Min Meng, Ph.D. “Denali was founded by a group of U.S.-trained bioanalytical experts in a state-of-the-art lab facility in China to provide exceptional service for domestic and international clients. We look forward to continuing this track record and offering even greater capabilities and trial flexibility as part of Resolian.” About Resolian Resolian (formerly Alliance Pharma Inc. and Drug Development Solutions Ltd.) is a leading global research laboratory that provides specialized services in GxP and nonregulated bioanalysis, drug metabolism/pharmacokinetics (DMPK), and GMP CMC analytical and materials science. Over 500 experts across the U.S., U.K., China, and Australia deliver quality results, ensuring the highest standard of regulatory compliance throughout the drug development continuum. Resolian’s dedicated laboratories are equipped with state-of-the-art technology that meet the needs of preclinical and clinical programs at any scale. About Denali Medpharma Denali is a China based bioanalytical CRO, now part of Resolian Bioanalytics. With 70 full-time employees, its core leadership have extensive working experience in the U.S. and China CRO industry. It is equipped with the world’s most advanced instruments. Denali’s quality assurance system is established in strict accordance with domestic and foreign laws and regulations related to bioanalysis. Denali is well known as the industry leader in China in the bioanalysis of oligonucleotide drugs and mRNA vaccines (PK/PD and ADA), liposomal drug (free and encapsulated drug), ultra-sensitive assays for inhalation drugs, and biomarker assays, etc. View source version on businesswire.com: https://www.businesswire.com/news/home/20231101490232/en/ Contact Lindsey Langemeier SCORR Marketing +1 402-405-4269 lindsey@scorrmarketing.com Source : Resolian |
Wednesday, 1 November 2023
MHTC COMMITS TO PROVIDE BREAST CANCER EARLY DETECTION ACCESSIBLE FOR EVERYONE
KUALA LUMPUR, Nov 1 (Bernama) -- Malaysia Healthcare Travel Council (MHTC), a government agency under the Ministry of Health Malaysia is encouraging global citizens to practice regular examinations and screenings as a crucial step in preventing breast cancer.
With healthcare facilities that are equipped with innovative screening procedures, MHTC in a statement said it is committed to making breast cancer early detection accessible for global citizens.
In conjunction with the breast cancer awareness month, the government agency shed light on the significance of early diagnosis as well as the cutting-edge screening procedures provided by several of its healthcare facilities.
“Individuals should be cautious about any lump in the breast or underarm (armpit), thickening or swelling on any part of the breast, skin irritation or dimpling, redness or flakiness around the nipple area or the breast, nipple inversion, pain in the nipple area, unusual nipple discharge that may include blood.
“Changes in breast size or shape and unexplained breast pain should also be regarded as warning signs,” said KPJ Perdana Specialist Hospital Consultant Radiologist, Dr Nik Munirah Nik Mahdi.
Meanwhile, Sunway Medical Centre in Sunway City Consultant Breast and Endocrine Surgeon, Dr Normayah Kitan said: “Doing regular breast self-examination is crucial to help you be aware of how your breasts normally look and feel, as well as detect symptoms such as lumps, pain, or abnormal changes in size.
“In addition to this, a clinical breast examination and screening every year should be done even if you do not detect any abnormalities, as breast cancer often does not present any symptoms at its earliest, which is the most treatable stage.”
Since its first cancer treatment centre was established in 1981, Malaysia has achieved international recognition for its quality of care and recently proclaimed as second in the care and delivery of cancer treatment in the Asia Pacific and the third-most prepared country overall by the Economist Intelligence Unit.
With a vast range of oncology services that include ground-breaking imaging and cancer detection technologies on offer, MHTC is moving forward steadily as the Cancer Care Centre of Excellence.
This is further reinforced by the country's excellent healthcare system, which makes it easier for healthcare travellers to obtain comprehensive cancer care promptly in a safe and trusted destination.
-- BERNAMA